日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.

蛋白质基因组表面组学研究发现 DLK1 是神经母细胞瘤的免疫治疗靶点

Hamilton Amber K, Radaoui Alexander B, Tsang Matthew, Martinez Daniel, Conkrite Karina L, Patel Khushbu, Sidoli Simone, Delaidelli Alberto, Modi Apexa, Rokita Jo Lynne, Lane Maria V, Hartnett Nicholas, Lopez Raphael D, Zhang Bo, Zhong Chuwei, Ennis Brian, Miller Daniel P, Brown Miguel A, Rathi Komal S, Raman Pichai, Pogoriler Jennifer, Bhatti Tricia, Pawel Bruce, Glisovic-Aplenc Tina, Teicher Beverly, Erickson Stephen W, Earley Eric J, Bosse Kristopher R, Sorensen Poul H, Krytska Kateryna, Mosse Yael P, Havenith Karin E, Zammarchi Francesca, van Berkel Patrick H, Smith Malcolm A, Garcia Benjamin A, Maris John M, Diskin Sharon J

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma

端粒维持机制决定高危神经母细胞瘤的临床结局

Koneru, Balakrishna; Lopez, Gonzalo; Farooqi, Ahsan; Conkrite, Karina L; Nguyen, Thinh H; Macha, Shawn J; Modi, Apexa; Rokita, Jo Lynne; Urias, Eduardo; Hindle, Ashly; Davidson, Heather; Mccoy, Kristyn; Nance, Jonas; Yazdani, Vanda; Irwin, Meredith S; Yang, Shengping; Wheeler, David A; Maris, John M; Diskin, Sharon J; Reynolds, C Patrick

Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma

生殖系 16p11.2 微缺失易导致神经母细胞瘤

Egolf, Laura E; Vaksman, Zalman; Lopez, Gonzalo; Rokita, Jo Lynne; Modi, Apexa; Basta, Patricia V; Hakonarson, Hakon; Olshan, Andrew F; Diskin, Sharon J